MedPath
NMPA Approval

Mirabegron Sustained-release Tablets

国药准字H20223358

May 31, 2022

Drug Information

米拉贝隆缓释片

片剂

50mg

化学药品

May 31, 2022

Company Information

Applicant Company

眉山经济开发区新区

Manufacturing Company

眉山市经济开发区新区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.